Molecular Determinants of TLR Trafficking
TLR 贩运的分子决定因素
基本信息
- 批准号:9120303
- 负责人:
- 金额:$ 76.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2018-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAutoimmune DiseasesAutoimmunityB-LymphocytesBiochemicalBiochemistryBiological AssayCarrier ProteinsCellsCellular biologyCleaved cellComplexDNADataDendritic CellsDevelopmentDiseaseDrug TargetingEarly EndosomeEndoplasmic ReticulumEndosomesFractionationGenesGenetic ScreeningGolgi ApparatusHealthImmuneImmune responseIndirect ImmunofluorescenceInfectionIntegral Membrane ProteinIntestinesKnock-in MouseKnowledgeMediatingMembraneMicroscopyModificationMolecularMolecular ChaperonesMultivesicular BodyOnset of illnessPathway interactionsPattern recognition receptorPhagosomesPlayPopulationProcessProteinsPublishingRNA interference screenRecruitment ActivityRoleSignal PathwaySignal TransductionSorting - Cell MovementStromal CellsSurfaceSystemTLR5 geneTLR7 geneTumor Necrosis Factor ReceptorUbiquitinUbiquitinationVesiclebasecell typecofactordrug developmentfunctional genomicsgenetic approachgenome-widehepatocyte growth factor-regulated tyrosine kinase substratein vivolate endosomemacrophagemicrobialpathogenreceptorresearch studysensortraffickingubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): TLR9 is an endosomally localized Pattern Recognition Receptor (PRR) that detects pathogen-associated DNA. TLR9 traffics from in the Endoplasmic Reticulum (ER) to the endolysosome, where it is cleaved and made competent for signaling activation. We have recently demonstrated that TLR9 is ubiquitinated and targeting of TLR9 to the early endosome is an ubiquitin-dependent process that is mediated by the ESCRT protein Hepatocyte Growth Factor Regulated Tyrosine Kinase Substrate (HRS). This compartmentalization is critical in mediating the signaling activation, as well as reducing the likelihood of triggering autoimmune disease. However, the molecular cofactors that enable TLR9 to transit from the ER to the endolysome are mostly uncharacterized. Here, we propose to identify the E3 ubiquitin ligase that is required for TLR9 ubiquitination using a high throughput genetic approach, as well as characterize the non-canonical role of ESCRT pathways components in TLR9 trafficking. In addition, we propose to validate 15 proteins identified by a genome-wide RNAi screen for TLR7/9 signaling for their potential roles in TLR7/9 endosomal trafficking. Finally, we propose to study the in vivo role of TLR9 ubiquitination and ESCRT function in TLR9 expressing cell subsets. Understanding the trafficking system of TLR9 is critical for the development of drugs for autoimmune diseases that results from promiscuous activation through endosomal TLR signaling.
描述(由申请人提供):TLR9是检测与病原体相关DNA的内体局部局部模式识别受体(PRR)。 TLR9从内质网中(ER)流量到内溶液体,在那里裂解并使信号激活具有胜任。我们最近证明,TLR9是泛素化的,TLR9靶向早期内体是泛素依赖性的过程,是由ESCRT蛋白肝细胞生长因子调节的酪氨酸激酶底物(HRS)介导的。这种分区化对于介导信号激活以及降低触发自身免疫性疾病的可能性至关重要。但是,使TLR9从ER转到内溶溶裂体的分子辅助因子大多没有表征。在这里,我们建议使用高吞吐量遗传方法来识别TLR9泛素化所需的E3泛素连接酶,并表征TLR9运输中ESCRT途径成分的非典型作用。此外,我们建议通过全基因组RNAi筛选鉴定出15种蛋白质,以实现TLR7/9信号传导,以便其在TLR7/9内体运输中的潜在作用。最后,我们建议研究TLR9泛素化和ESCRT功能在TLR9表达细胞亚群中的体内作用。了解TLR9的运输系统对于通过内体TLR信号传导引起的自身免疫性疾病的药物开发至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory M Barton其他文献
Gregory M Barton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory M Barton', 18)}}的其他基金
The Signal Transduction in the Immune System Conference
免疫系统会议中的信号转导
- 批准号:
10683527 - 财政年份:2023
- 资助金额:
$ 76.96万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10438923 - 财政年份:2021
- 资助金额:
$ 76.96万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10650735 - 财政年份:2021
- 资助金额:
$ 76.96万 - 项目类别:
Control of Regulatory T Cell Function by Toll-Like Receptor 7
Toll 样受体 7 对调节性 T 细胞功能的控制
- 批准号:
10304769 - 财政年份:2021
- 资助金额:
$ 76.96万 - 项目类别:
The influence of maternal antibodies on neonatal intestinal immunity
母源抗体对新生儿肠道免疫的影响
- 批准号:
9677877 - 财政年份:2018
- 资助金额:
$ 76.96万 - 项目类别:
The influence of maternal antibodies on neonatal intestinal immunity
母源抗体对新生儿肠道免疫的影响
- 批准号:
9790941 - 财政年份:2018
- 资助金额:
$ 76.96万 - 项目类别:
相似国自然基金
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
- 批准号:32370955
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
磷酸酶PP2A促进滤泡辅助性T细胞分化及相关自身免疫性疾病的作用和机制研究
- 批准号:31900628
- 批准年份:2019
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
基于表达MHC-肽嵌合抗原受体T细胞治疗自身免疫疾病的策略和机制研究
- 批准号:81901643
- 批准年份:2019
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
系统性红斑狼疮患者泌乳素对调节性B细胞的调控作用及其影响自身抗体分泌的研究
- 批准号:81803129
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
CCR4控制调节性T细胞的空间分布及其对自身免疫性疾病的作用
- 批准号:31870871
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Potential of tissue kallikreins as therapeutic targets for neuropsychiatric lupus
组织激肽释放酶作为神经精神狼疮治疗靶点的潜力
- 批准号:
10667764 - 财政年份:2023
- 资助金额:
$ 76.96万 - 项目类别:
Mining host-microbe interactions in the neonatal pancreas to combat diabetes
挖掘新生儿胰腺中宿主-微生物的相互作用来对抗糖尿病
- 批准号:
10664448 - 财政年份:2023
- 资助金额:
$ 76.96万 - 项目类别:
Build to LEAD – Building partnerships to Link the Exposome to Autoimmune Disease
构建引领 — 建立合作伙伴关系,将暴露组与自身免疫性疾病联系起来
- 批准号:
10871040 - 财政年份:2023
- 资助金额:
$ 76.96万 - 项目类别:
Mitochondrial Membrane Dynamics in Th17 Cells
Th17 细胞的线粒体膜动力学
- 批准号:
10733013 - 财政年份:2023
- 资助金额:
$ 76.96万 - 项目类别:
Defining the Role of Enteric Nervous System Dysfunction in Gastrointestinal Motor and Sensory Abnormalities in Down Syndrome
确定肠神经系统功能障碍在唐氏综合症胃肠运动和感觉异常中的作用
- 批准号:
10655819 - 财政年份:2023
- 资助金额:
$ 76.96万 - 项目类别: